| Literature DB >> 36010914 |
Fang Bao1,2,3, Jiayue Liu1,2, Haiyang Chen1,2, Lu Miao3, Zhaochao Xu3, Guixin Zhang1,2.
Abstract
Cholangiocarcinoma (CCA) is a multifactorial malignant tumor of the biliary tract, and the incidence of CCA is increasing in recent years. At present, the diagnosis of CCA mainly depends on imaging and invasive examination, with limited specificity and sensitivity and late detection. The early diagnosis of CCA always faces the dilemma of lacking specific diagnostic biomarkers. Non-invasive methods to assess the degree of CAA have been developed throughout the last decades. Among the many specimens looking for CCA biomarkers, bile has gotten a lot of attention lately. This paper mainly summarizes the recent developments in the current research on the diagnostic biomarkers for CCA in human bile at the levels of the gene, protein, metabolite, extracellular vesicles and volatile organic compounds.Entities:
Keywords: bile; biomarker; cholangiocarcinoma; diagnosis
Year: 2022 PMID: 36010914 PMCID: PMC9406189 DOI: 10.3390/cancers14163921
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.575